New England Investment & Retirement Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$473K Buy
10,988
+912
+9% +$40.4K 0.11% 68
2021
Q2
$395K Buy
+10,076
New +$392K 0.09% 77
2020
Q2
Sell
-843
Closed -$26K 172
2020
Q1
$26K Buy
+843
New +$28.7K 0.01% 108
2013
Q3
Sell
-31,705
Closed -$843K 61
2013
Q2
$843K Buy
+31,705
New +$876K 0.53% 37

Other funds holding PFE

New England Investment & Retirement Group's PFE Position: Q3 2021 in Review

New England Investment & Retirement Group increased its Pfizer (PFE) stake by 9.1% in Q3 2021, buying an estimated $40.4K and bringing the position to 10,988 shares worth $473K. The position accounts for 0.11% of the portfolio, ranked #68.

New England Investment & Retirement Group first reported a position in PFE in Q2 2013 and has held it in 4 quarters since. The position peaked at $843K in Q2 2013. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • New England Investment & Retirement Group held 10,988 shares of Pfizer worth $473K as of Q3 2021.
  • New England Investment & Retirement Group bought 912 Pfizer shares in Q3 2021, an estimated $40.4K.
  • Pfizer made up 0.11% of New England Investment & Retirement Group's portfolio in Q3 2021, its #68 holding.
  • New England Investment & Retirement Group first reported a position in Pfizer in Q2 2013 and has held it in 4 quarters since.
  • New England Investment & Retirement Group's Pfizer position peaked at $843K in Q2 2013.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on New England Investment & Retirement Group's 13F filing for Q3 2021, filed 28 Oct 2021.